Search for: "Akorn Inc."
Results 41 - 54
of 54
Sort by Relevance
|
Sort by Date
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
20 Jul 2018, 11:44 pm
TevaPharmaceuticals USA, Inc., and Akorn, Inc. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
30 Nov 2016, 10:22 am
Defendant Akorn, Inc., a generic drugmaker based in Lake Forest, Illinois, filed an Abbreviated New Drug Application (“ANDA”) with the U.S. [read post]
19 Jul 2015, 9:59 pm
Akorn Inc. 1:15-cv-00474; filed June 11, 2015 in the District Court of Delaware Infringement of U.S. [read post]
9 Sep 2013, 9:27 pm
• Defendant: Akorn, Inc. [read post]
25 Apr 2012, 9:05 am
The owners of the three approved ANDAs for generic oral vancomycin—Akorn, Incorporated (“Akorn”), Watson Laboratories, Inc. [read post]
10 Apr 2012, 3:53 pm
FDA also states in the petition response that the Agency approved three ANDAs for generic VANCOCIN, including one from Akorn, Inc. [read post]
5 Apr 2012, 9:19 am
Finally last December Lundbeck sold its pentobarbital rights to Illinois-based Akorn Inc., which signed an agreement promising it would not sell the drug for the purpose of executions. [read post]
24 Jan 2012, 6:34 pm
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
26 Dec 2011, 7:37 pm
• Defendants: Akorn Inc.; Akorn Ophthalmics Inc. [read post]
19 Apr 2011, 8:23 am
ANDA sponsor Akorn, Inc. [read post]
28 Sep 2008, 3:26 am
Two companies, Alcon Laboratories and Akorn, Inc. have versions that are officially approved by the FDA, and are not affected by this crackdown. [read post]
